Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Ratos AB ( ($SE:RATO.B) ).
Ratos announced a positive earnings impact of approximately SEK 300 million due to an arbitration award involving its subsidiary, Diab Group. The decision to decrease Diab’s PET production capacity and impair certain assets will also enhance cash flow by SEK 600 million, reflecting Ratos’s ongoing strategy to streamline operations.
The most recent analyst rating on ($SE:RATO.B) stock is a Buy with a SEK45.00 price target. To see the full list of analyst forecasts on Ratos AB stock, see the SE:RATO.B Stock Forecast page.
More about Ratos AB
Ratos is a Swedish publicly listed business group with 14 companies in Construction & Services, Industry, and Consumer sectors, primarily operating in the Nordic region. The group reported net sales of SEK 32 billion in 2024 and employs around 10,900 people. Ratos emphasizes simplicity, speed in execution, and a people-focused culture, supporting its subsidiaries to thrive independently.
Average Trading Volume: 545,588
Technical Sentiment Signal: Buy
Current Market Cap: SEK11.55B
For a thorough assessment of RATO.B stock, go to TipRanks’ Stock Analysis page.